Bioaffinity Technologies, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Bioaffinity Technologies, Inc.
Quantité totale PI 34
Rang # Quantité totale PI 43 670
Note d'activité PI 2,3/5.0    22
Rang # Activité PI 37 269
Symbole boursier BIAF (nasdaq)
Capitalisation 19.80M  (USD)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

7 10
5 0
8 4
0
 
Dernier brevet 2025 - Compositions and methods for tre...
Premier brevet 2001 - Compositions and methods for det...
Dernière marque 2026 - FLOWPATH
Première marque 2004 - CYPATH

Industrie (Classification de Nice)

Derniers inventions, produits et services

2026 P/S Cancer screening test kit comprised of implements and container for collecting patient biological...
2025 Invention Compositions and methods for treating cancer. A method of inhibiting skin cancer by administerin...
2024 Invention Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learnin...
Invention Compositions and methods for use in flow cytometry. A compensation bead comprising an amine func...
P/S Providing information to patients in the field of medical diagnostic screening; providing medical...
2023 Invention Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning
2022 Invention Compositions and methods for use in flow cytometry. A compound comprising an amine functionalized...
Invention Compositions and methods for treating cancer. A double stranded RNA interference (RNAi) agent com...
Invention Compositions and methods for treating cancer. iiiiiiiiiii) and wherein the sense strand of the fi...
2021 Invention Compositions and methods for cellular delivery of rna. One embodiment of the present invention pr...
Invention Compositions and methods for treating cancer. A compound, pharmaceutical composition made therefr...
2020 Invention System and method for determining lung health. Predicting the likelihood of lung disease in a su...
2019 Invention System and method for determining lung health. Predicting the likelihood of lung disease in a sub...
2018 P/S Chemical agents and preparations for medical and clinical laboratory diagnostic use; assay kits ...
P/S Cancer screening test kit comprised of implements and container for collecting patient samples f...
P/S Chemical agents and preparations for clinical laboratory diagnostic use for treatment of cancer
2016 P/S Chemical agents and preparations for scientific purposes other than for medical or veterinary us...
P/S Chemical agents and preparations for scientific purposes other than for medical or veterinary use...
2015 P/S [ Chemical agents and preparations for scientific purposes other than for medical or veterinary u...
Invention 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine (tcpp) and kit for use with detecting cancer. Pre...
2014 Invention System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) por...
P/S Research and development services in the area of cancer therapeutics and assays
2013 Invention Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) p...
2011 Invention Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porp...
2008 Invention Method for making 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine (tcpp) solution and composition...
2004 P/S Chemical agents and preparations for medical and clinical laboratory diagnostic use; Assay kits c...
2001 Invention Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using ...
Invention Method of making 5, 10, 15, 20-tetrakis(carboxyphenyl) porphine solutions and compositions thereo...